The markets opened higher with the Dow rising 33 points to 22,090 as investors await the unveiling of Apple's new iPhones. Nasdaq gained 16 points to 6,448.
On the upside
The Food and Drug Administration accepted Teva Pharmaceutical's (NYSE: TEVA) supplemental New Drug Application for TRISENOX to treat patients with low to intermediate risk of acute promyelocytic leukemia.
Southwestern Energy (NYSE: SWN) priced its public offering of $1.15 billion in senior notes.
BidaskClub upgraded Perrigo (NYSE: PRGO) from a Strong Sell rating to a Sell rating.
On the downside
Intercept Pharmaceuticals (Nasdaq: ICPT) will present at the Morgan Stanley 15th Annual Global Healthcare Conference today.
Sage Therapeutics (Nasdaq: SAGE) reported disappointing results from a Phase 3 STATUS Trial of brexanolone to treat super-refractory status epilepticus.
Brookfield Infrastructure Partners (NYSE: BIP) will offer $1 billion in redeemable partnership units and L.P. units.
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 added 3 points to 2,491. Bitcoin soared $92 to $4,284.
